Patricia M Horvath1, Ege T Kavalali2, Lisa M Monteggia3. 1. Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA. 2. Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Physiology, UT Southwestern Medical Center, Dallas, TX 75390, USA. 3. Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: lisa.monteggia@utsouthwestern.edu.
Abstract
BACKGROUND: The use of the CRISPR/Cas9 system is becoming widespread, however current studies have predominantly focused on dividing cells. It is currently unknown if CRISPR/Cas9 can be used in a postmitotic setting to examine non-cell autonomous/presynaptic phenotypes in the resulting genetically heterogeneous cell population. NEW METHOD: A single CRISPR/Cas9 lentivirus was used to transfect a high percentage of primary cultured neurons and target synaptobrevin 2 (Syb2, also called VAMP2). RESULTS: Primary hippocampal cultures infected with the Syb2 targeting virus displayed dramatic reductions in Syb2 protein and immunocytochemical staining. In many boutons Syb2 was completely undetected. These cultures recapitulated the known functional phenotypes of Syb2 knockout neurons, which are non-cell autonomous and presynaptic in origin, indicating that Syb2 was knocked out in a large fraction of neurons. COMPARISON WITH EXISTING METHOD(S): Previous methods used multiple viruses or sparse transfection methods and only examined cell autonomous or postsynaptic phenotypes. The current method demonstrates that the CRISPR/Cas9 system can be used to alter network dynamics by removing or lowering the target gene from a majority of cells in the culture. CONCLUSIONS: A combination of CRISPR/Cas9 system and single high efficiency lentivirus infection can be used to examine non-cell autonomous and presynaptic phenotypes in postmitotic neurons.
BACKGROUND: The use of the CRISPR/Cas9 system is becoming widespread, however current studies have predominantly focused on dividing cells. It is currently unknown if CRISPR/Cas9 can be used in a postmitotic setting to examine non-cell autonomous/presynaptic phenotypes in the resulting genetically heterogeneous cell population. NEW METHOD: A single CRISPR/Cas9 lentivirus was used to transfect a high percentage of primary cultured neurons and target synaptobrevin 2 (Syb2, also called VAMP2). RESULTS: Primary hippocampal cultures infected with the Syb2 targeting virus displayed dramatic reductions in Syb2 protein and immunocytochemical staining. In many boutons Syb2 was completely undetected. These cultures recapitulated the known functional phenotypes of Syb2 knockout neurons, which are non-cell autonomous and presynaptic in origin, indicating that Syb2 was knocked out in a large fraction of neurons. COMPARISON WITH EXISTING METHOD(S): Previous methods used multiple viruses or sparse transfection methods and only examined cell autonomous or postsynaptic phenotypes. The current method demonstrates that the CRISPR/Cas9 system can be used to alter network dynamics by removing or lowering the target gene from a majority of cells in the culture. CONCLUSIONS: A combination of CRISPR/Cas9 system and single high efficiency lentivirus infection can be used to examine non-cell autonomous and presynaptic phenotypes in postmitotic neurons.
Authors: James E Dahlman; Omar O Abudayyeh; Julia Joung; Jonathan S Gootenberg; Feng Zhang; Silvana Konermann Journal: Nat Biotechnol Date: 2015-11 Impact factor: 54.908
Authors: Ana Cicvaric; Hannah M Sachernegg; Tamara Stojanovic; Dörte Symmank; Tarik Smani; Thomas Moeslinger; Pavel Uhrin; Francisco J Monje Journal: Front Cell Neurosci Date: 2020-01-15 Impact factor: 5.505
Authors: Sam Hana; Michael Peterson; Helen McLaughlin; Eric Marshall; Attila J Fabian; Olivia McKissick; Kathryn Koszka; Galina Marsh; Michael Craft; Shanqin Xu; Alexander Sorets; Tess Torregrosa; Chao Sun; Chris E Henderson; Shih-Ching Lo Journal: Gene Ther Date: 2021-02-08 Impact factor: 5.250